SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Apogee 21 Holdings, Inc. (APHD) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 15/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — APHD
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio52.84
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.13
Book Value / Share$0.00
Revenue / Share$0.02
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$-5.20 |
$738.17K |
$-1.6M |
-216.7% |
| 2016 |
$-0.01 |
$904.00 |
$-145.29K |
-16072.2% |
| 2017 |
$-0.04 |
$50.3K |
$-2.47M |
-4918.4% |
| 2018 |
$-0.12 |
$41.85K |
$-1.79M |
-4287.5% |
| 2019 |
$-0.06 |
$0.00 |
$-887.41K |
- |
| 2020 |
$-1.18 |
$0.00 |
$-1.81M |
- |
| 2021 |
$1.64 |
$0.00 |
$990.47K |
- |
| 2022 |
$-0.26 |
$0.00 |
$-111.22K |
- |
| 2023 |
$0.00 |
$926.1K |
$0.00 |
0% |
| 2025 |
$-0.13 |
$256.76K |
$-1.86M |
-725.4% |
